Back to Results
First PageMeta Content



1 Phase I Study of Safety and Pharmacokinetics of GDC-0917, an Antagonist of Inhibitor of Apoptosis Proteins in Patients with Refractory Solid Tumors or Lymphoma
Add to Reading List

Document Date: 2014-05-12 19:51:02


Open Document

File Size: 641,52 KB

Share Result on Facebook
UPDATE